4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001415889-24-020626
CFO, EVP & TREASURER sold 10,282 shares at $44.23 ($454,773)
- CFO, EVP & TREASURER acquired 10,282 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PETERS WILLIAM J CFO, EVP & TREASURER | 2024-07-31 | Option exercise 10b5-1 | +10,282 | $20.23 | $208,005 | 104,385 | D |
| PETERS WILLIAM J CFO, EVP & TREASURER | 2024-07-31 | Sale 10b5-1 | −10,282 | $44.23 | $454,773 | 94,103 | D |
| Derivatives | |||||||
| PETERS WILLIAM J CFO, EVP & TREASURER | 2024-07-31 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −10,282 | 4,943 | D | ||
| Open-market sales · 10,282 sh · avg $44.23 · $454,773 | |||||||
Loading xslF345X05/form4-08022024_080849.xml…